CML is a hematopoietic disorder characterized by the malignant expansion of bone marrow stem cells, with the presence of a reciprocal translocation between chromosomes 9 and 22 resulting in activation of fusion gene BCR-ABL expression (45). The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.